share_log
Reuters ·  Apr 29 08:45
Sellas Life Sciences Group Inc: Next Efficacy and Safety Assessment of All Regal Patients (N=127) in June 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment